Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine.

Modulation of urinary excretion of green tea polyphenols (GTPs) and oxidative DNA damage biomarker, 8-hydroxydeoxyguanosine (8-OHdG), were assessed in urine samples collected from a randomized, double-blinded and placebo-controlled phase IIa chemoprevention trial with GTP in 124 individuals. These individuals were sero-positive for both HBsAg and aflatoxin-albumin adducts, and took GTP capsules daily at doses of 500 mg, 1000 mg or a placebo for 3 months. Twenty-four hour urine samples were collected before the intervention and at the first and third month of the study. Urinary excretion of 8-OHdG and GTP components was measured by HPLC-CoulArray electrochemical detection. The baseline levels of 8-OHdG and GTP components among the three groups showed homogeneity (P > 0.70), and a non-significant fluctuation was observed in the placebo group over the 3 months (P > 0.30). In GTP-treated groups, epigallocatechin (EGC) and epicatechin (EC) levels displayed significant and dose-dependent increases in both the 500 mg group and 1000 mg group (P < 0.05). The 8-OHdG levels did not differ between the three groups at the 1 month collection, with medians of 1.83, 2.08 and 1.86 ng/mg-creatinine for placebo, 500 and 1000 mg group, respectively (P = 0.999). At the end of the 3 months' intervention, 8-OHdG levels decreased significantly in both GTP-treated groups, with medians of 2.02, 1.03 and 1.15 ng/mg-creatinine for placebo, 500 mg and 1000 mg group, respectively (P = 0.007). These results suggest that urinary excretions of EGC and EC can serve as practical biomarkers for green tea consumption in human populations. The results also suggest that chemoprevention with GTP is effective in diminishing oxidative DNA damage.

[1]  H N Graham,et al.  Green tea composition, consumption, and polyphenol chemistry. , 1992, Preventive medicine.

[2]  Maojung Lee,et al.  Absorption, Distribution, and Elimination of Tea Polyphenols in Rats , 1997 .

[3]  Cancer chemoprevention. A new way to treat cancer before it happens. , 1998, Primary care.

[4]  L. Loeb,et al.  8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions. , 1992, The Journal of biological chemistry.

[5]  S. Hirohashi,et al.  Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. , 1994, Cancer research.

[6]  Lili Tang,et al.  Epidemiology of Aflatoxin Exposure and Human Liver Cancer , 2004 .

[7]  J. Klaunig.  Chemopreventive effects of green tea components on hepatic carcinogenesis. , 1992, Preventive medicine.

[8]  Zuo-Feng Zhang,et al.  Protective effect of green tea on the risks of chronic gastritis and stomach cancer , 2001, International journal of cancer.

[9]  G. Scherer,et al.  Fast quantification of the urinary marker of oxidative stress 8-hydroxy-2'-deoxyguanosine using solid-phase extraction and high-performance liquid chromatography with triple-stage quadrupole mass detection. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[10]  Y. Hara,et al.  Antimutagenic and anticarcinogenic activity of tea polyphenols. , 1999, Mutation research.

[11]  Steen Steenken,et al.  Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e- and OH adducts , 1989 .

[12]  J. Cadet,et al.  Photosensitized formation of 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in DNA by riboflavin. , 1992, Nucleic acids symposium series.

[13]  Jian-Min Yuan,et al.  Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. , 2002, Carcinogenesis.

[14]  H. Moriwaki.  Determination of 8-Hydroxy-2′-deoxyguanosine in Urine by Liquid Chromatography–Electrospray Ionization–Mass Spectrometry , 2000 .

[15]  T. Umemura,et al.  Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[17]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[18]  A. Collins,et al.  Oxidative stress in humans: validation of biomarkers of DNA damage. , 2002, Carcinogenesis.

[19]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[20]  H. Mukhtar,et al.  Tea in chemoprevention of cancer. , 1996, International journal of oncology.

[21]  M. Evans,et al.  Oxidative DNA damage and disease: induction, repair and significance. , 2004, Mutation research.

[22]  C. Anderson,et al.  Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence , 2005 .

[23]  S. J. Culp,et al.  Structural and conformational analyses of 8-hydroxy-2'-deoxyguanosine. , 1989, Chemical research in toxicology.

[24]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[26]  J. Singer,et al.  Applied Longitudinal Data Analysis , 2003 .

[27]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  E. Mohler,et al.  The effect of tea consumption on oxidative stress in smokers and nonsmokers. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[29]  Sandra N. Mohr,et al.  Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  J. Groopman,et al.  Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. , 1996, Canadian journal of physiology and pharmacology.

[31]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[32]  C. Ong,et al.  Involvement of reactive oxygen species in aflatoxin B1-induced cell injury in cultured rat hepatocytes. , 1995, Toxicology.

[33]  Chung S. Yang,et al.  Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. , 2003, Mutation research.

[34]  R. Agarwal,et al.  Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. , 1997, Journal of the National Cancer Institute.

[35]  G. Wogan.  Aflatoxins as risk factors for hepatocellular carcinoma in humans. , 1992, Cancer research.

[36]  D. Mitchell,et al.  Effect of oxidative DNA damage in promoter elements on transcription factor binding. , 1999, Nucleic acids research.

[37]  Samuel H. Wilson,et al.  “Action-at-a-Distance” Mutagenesis , 1999, The Journal of Biological Chemistry.

[38]  S. Loft,et al.  Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. , 1998, Free radical research.

[39]  May-Chen Kuo,et al.  Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  J. Peters,et al.  Action at a Distance , 2020 .

[41]  Chung S. Yang,et al.  Mechanisms of cancer prevention by tea constituents. , 2003, The Journal of nutrition.

[42]  A. Tamakoshi,et al.  Tea Consumption and Lung Cancer Risk: A Case‐Control Study in Okinawa, Japan , 1995, Japanese journal of cancer research : Gann.

[43]  D. Gingras,et al.  Green tea catechins as novel antitumor and antiangiogenic compounds. , 2002, Current medicinal chemistry. Anti-cancer agents.

[44]  J. Yudkin,et al.  Tea consumption and cancer. , 1988, British Journal of Cancer.

[45]  Alexander Pilger,et al.  Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults , 2001, Free radical research.

[46]  H. Li,et al.  Analysis of plasma and urinary tea polyphenols in human subjects. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  C. Harris,et al.  Multifactoral etiology of human liver cancer. , 1984, Carcinogenesis.

[48]  J K McLaughlin,et al.  Reduced risk of esophageal cancer associated with green tea consumption. , 1994, Journal of the National Cancer Institute.